tm logo
AMERICA'S BIOPHARMACEUTICAL COMPANIES
Live/Registered
REGISTERED

on 20 Apr 2021

Last Applicant/ Owned by

Serial Number

87347024 filed on 23rd Feb 2017

Registration Number

6329053 registered on 20th Apr 2021

in the Principal Register

Correspondent Address

B. Brett Heavner

Finnegan, Henderson, Farabow, Garrett &

901 New York Avenue NW

Washington,DC 20001

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"AMERICA'S BIOPHARMACEUTICAL COMPANIES"

AMERICA'S BIOPHARMACEUTICAL COMPANIES

Providing online information regarding medical and scientific research in the field of biopharmaceuticals; providing online information on biopharmaceutical research; providing online information in the field of biopharmaceuticals and biopharmaceutical industry regarding biopharmaceutical safety in the nature of biopharmaceutical testing "AMERICA'S BIOPHARMACEUTICAL COMPANIES" Association servicRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Providing online information regarding medical and scientific research in the field of biopharmaceuticals; providing online information on biopharmaceutical research; providing online information in the field of biopharmaceuticals and biopharmaceutical industry regarding biopharmaceutical safety in the nature of biopharmaceutical testing


First Use Date in General

31st Dec 2016

First Use Date in Commerce

31st Dec 2016

Class [041]
Education and Entertainment Services


Providing a website featuring non-downloadable publications in the nature of testimonials, infographics, fact sheets, reports, articles, and videos regarding biopharmaceuticals and the biopharmaceutical industry


First Use Date in General

31st Dec 2016

First Use Date in Commerce

31st Dec 2016

Class [035]
Advertising, Business & Retail Services


Association services, namely, promoting the interests of research-based prescription drug manufacturers


First Use Date in General

31st Dec 2016

First Use Date in Commerce

31st Dec 2016

Class [009]
Computer & Software Products & Electrical & Scientific Products


Electronic downloadable publications in the nature of fact sheets, reports, and infographics regarding biopharmaceuticals and the biopharmaceutical industry


First Use Date in General

31st Dec 2016

First Use Date in Commerce

31st Dec 2016

Mark Details


Serial Number

No 87347024

Mark Type

No Service Mark

Attorney Docket Number

No 03598.0278

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

07.15.25 -

Other building materials, including tiles

26.09.21 -

Squares that are completely or partially shaded

26.11.09 -

Rectangles made of geometric figures, objects, humans, plants or animals

26.11.14 -

Three or more rectangles

26.11.21 -

Rectangles that are completely or partially shaded

Description of Design Search

The mark consists of the white stylized wording "AMERICA'S BIOPHARMACEUTICAL COMPANIES" to the right of a rectangular pattern formed by three rows of tiles of varying lengths. The tiles in the top row are, from left to right, a forest green rectangle and an apple green rectangle. The tiles in the middle row are, from left to right, a kelly green rectangle, a forest green rectangle, and a yellow rectangle. The tiles in the bottom row are, from left to right, an apple green square, a teal rectangle, and a mint green rectangle. The black is not part of the mark and represents background area.

Legal History


Show more

Status DateAction Taken
07th Mar 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
07th Mar 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07th Mar 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07th Mar 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07th Mar 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
20th Apr 2021REGISTERED-PRINCIPAL REGISTER
16th Mar 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
15th Mar 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12th Mar 2021TEAS/EMAIL CORRESPONDENCE ENTERED
11th Mar 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED